Nigeria · Healthcare · NGN · Quarterly
Reported figures and Equlion model projections for the next 12 periods.
Amounts in NGN; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for NEIMETH INTERNATIONAL PHARMACEUTICALS PLC? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Metric | 2025 | Period 1 | Period 2 | Period 3 | Period 4 | Period 5 | Period 6 | Period 7 | Period 8 | Period 9 | Period 10 | Period 11 | Period 12 |
| ROE | 9.29% | -0.11% | -0.11% | -0.11% | -0.11% | -0.13% | -0.11% | -0.11% | -0.11% | -0.11% | -0.11% | ||
| -0.11% |
| -0.11% |
| ROA | 1.74% | -0.02% | -0.02% | -0.02% | -0.02% | -0.02% | -0.02% | -0.02% | -0.02% | -0.02% | -0.02% | -0.02% | -0.02% |
|---|
| Gross Margin | -12.5% | 15% | 15% | 15% | 15% | 15.78% | 15% | 15% | 15% | 15% | 15% | 15% | 15% |
|---|
| Total Assets | NGNÂ 14,014,101.00 | NGNÂ 14,014,101.00 | NGNÂ 14,014,101.00 | NGNÂ 14,014,101.00 | NGNÂ 14,014,101.00 | NGNÂ 14,014,101.00 | NGNÂ 14,014,101.00 | NGNÂ 14,014,101.00 | NGNÂ 14,014,101.00 | NGNÂ 14,014,101.00 | NGNÂ 14,014,101.00 | NGNÂ 14,014,101.00 | NGNÂ 14,014,101.00 |
|---|
| Net Income | NGNÂ 244,104.25 | -NGNÂ 2,845.78 | -NGNÂ 2,846.50 | -NGNÂ 2,847.23 | -NGNÂ 2,847.95 | -NGNÂ 3,275.23 | -NGNÂ 2,849.49 | -NGNÂ 2,850.22 | -NGNÂ 2,850.94 | -NGNÂ 2,851.66 | -NGNÂ 2,852.39 | -NGNÂ 2,853.11 | -NGNÂ 2,853.83 |
|---|